The skull base chordoma patient reported outcome survey (sbCPROS): a patient-centered, disease-specific tool for assessing quality of life in chordoma patients.

IF 3.1 2区 医学 Q2 CLINICAL NEUROLOGY Journal of Neuro-Oncology Pub Date : 2025-05-01 Epub Date: 2025-02-19 DOI:10.1007/s11060-025-04974-6
Saket Myneni, Linda Tang, Hanan Akbari, Raquel Mayne, A Karim Ahmed, Foad Kazemi, Nicolas Dea, Nathan T Zwagerman, Shirley Y Su, Garret Choby, Eric W Wang, Kristin J Redmond, Erin L McKean, Carl H Snyderman, Nicholas R Rowan, Debraj Mukherjee
{"title":"The skull base chordoma patient reported outcome survey (sbCPROS): a patient-centered, disease-specific tool for assessing quality of life in chordoma patients.","authors":"Saket Myneni, Linda Tang, Hanan Akbari, Raquel Mayne, A Karim Ahmed, Foad Kazemi, Nicolas Dea, Nathan T Zwagerman, Shirley Y Su, Garret Choby, Eric W Wang, Kristin J Redmond, Erin L McKean, Carl H Snyderman, Nicholas R Rowan, Debraj Mukherjee","doi":"10.1007/s11060-025-04974-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Chordomas are rare malignant tumors arising from the embryological notochord that present most frequently in the lumbosacral spine, followed by the skull base, with an overall 1/1,000,000 incidence. These tumors and their treatment significantly affect quality of life (QOL) due to intricate anatomical locations and aggressive treatment regimens. Despite these challenges, there are currently no disease-specific patient-reported outcome (PRO) surveys for chordomas. We aimed to develop a tool to assess QOL in patients with skull base chordomas (sbCs).</p><p><strong>Methods: </strong>Twenty-seven patients who underwent sbC resection were interviewed on QOL throughout their care. Grounded-theory analysis of interview transcripts generated 7 themes. We developed an initial survey with 79 items from existing general and anatomic-specific QOL assessment tools addressing these themes. Ten chordoma providers and 10 new patients completed an anonymous Qualtrics survey, rating items' relevance on a 5-point Likert scale to validate survey content. An a priori cutoff of > 3.0 was used for significant relevance. Mean relevance scores for each item were compared between providers and patients as well as between skull base respondents and 5 control patients with lumbar spine and sacral chordomas, using two-sided Mann-Whitney U-tests.</p><p><strong>Results: </strong>Seventy-four items reached the relevance threshold. These were consolidated to create the final 42-item Skull Base Chordoma Patient Reported Outcome Survey (sbCPROS). Providers significantly overvalued items related to the themes of pain (73%), sleep changes (60%), and sensory & motor symptoms (43%) relative to patients. Ten items were more relevant to skull base patients than patients with spinal tumors (p < 0.05).</p><p><strong>Conclusion: </strong>The authors developed a novel patient-centered, disease-specific PRO instrument to assess change in QOL for sbC patients over time. sbCPROS may provide significant insight into the delivery of high quality care for patients with sbCs and guide patient-physician discussions about care decision-making.</p>","PeriodicalId":16425,"journal":{"name":"Journal of Neuro-Oncology","volume":" ","pages":"157-166"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neuro-Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11060-025-04974-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Chordomas are rare malignant tumors arising from the embryological notochord that present most frequently in the lumbosacral spine, followed by the skull base, with an overall 1/1,000,000 incidence. These tumors and their treatment significantly affect quality of life (QOL) due to intricate anatomical locations and aggressive treatment regimens. Despite these challenges, there are currently no disease-specific patient-reported outcome (PRO) surveys for chordomas. We aimed to develop a tool to assess QOL in patients with skull base chordomas (sbCs).

Methods: Twenty-seven patients who underwent sbC resection were interviewed on QOL throughout their care. Grounded-theory analysis of interview transcripts generated 7 themes. We developed an initial survey with 79 items from existing general and anatomic-specific QOL assessment tools addressing these themes. Ten chordoma providers and 10 new patients completed an anonymous Qualtrics survey, rating items' relevance on a 5-point Likert scale to validate survey content. An a priori cutoff of > 3.0 was used for significant relevance. Mean relevance scores for each item were compared between providers and patients as well as between skull base respondents and 5 control patients with lumbar spine and sacral chordomas, using two-sided Mann-Whitney U-tests.

Results: Seventy-four items reached the relevance threshold. These were consolidated to create the final 42-item Skull Base Chordoma Patient Reported Outcome Survey (sbCPROS). Providers significantly overvalued items related to the themes of pain (73%), sleep changes (60%), and sensory & motor symptoms (43%) relative to patients. Ten items were more relevant to skull base patients than patients with spinal tumors (p < 0.05).

Conclusion: The authors developed a novel patient-centered, disease-specific PRO instrument to assess change in QOL for sbC patients over time. sbCPROS may provide significant insight into the delivery of high quality care for patients with sbCs and guide patient-physician discussions about care decision-making.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
颅底脊索瘤患者报告结果调查(sbCPROS):一种以患者为中心、疾病特异性的评估脊索瘤患者生活质量的工具。
目的:脊索瘤是起源于胚胎脊索的罕见恶性肿瘤,最常见于腰骶棘,其次是颅底,总体发病率为百万分之一。由于复杂的解剖位置和积极的治疗方案,这些肿瘤及其治疗显著影响生活质量(QOL)。尽管存在这些挑战,目前还没有针对脊索瘤的疾病特异性患者报告结果(PRO)调查。我们的目的是开发一种评估颅底脊索瘤(sbCs)患者生活质量的工具。方法:对27例行sbC切除术的患者在整个治疗过程中的生活质量进行访谈。基于理论的访谈记录分析产生了7个主题。针对这些主题,我们从现有的一般和解剖特异性生活质量评估工具中选取了79个项目进行了初步调查。10名脊索瘤提供者和10名新患者完成了一项匿名质量调查,以5分李克特量表对项目的相关性进行评级,以验证调查内容。采用bbb3.0的先验截止值表示显著相关性。采用双侧Mann-Whitney u检验,比较提供者和患者之间以及颅底应答者和5名腰椎和骶脊索瘤对照患者之间每个项目的平均相关性评分。结果:74项达到相关阈值。这些结果被合并成最终的42项颅底脊索瘤患者报告结果调查(sbCPROS)。相对于患者而言,提供者明显高估了与疼痛(73%)、睡眠变化(60%)以及感觉和运动症状(43%)相关的项目。结论:作者开发了一种新的以患者为中心的疾病特异性PRO仪器来评估sbC患者生活质量随时间的变化。sbCPROS可以为sbc患者提供高质量护理的重要见解,并指导患者与医生讨论护理决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Neuro-Oncology
Journal of Neuro-Oncology 医学-临床神经学
CiteScore
6.60
自引率
7.70%
发文量
277
审稿时长
3.3 months
期刊介绍: The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system. It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research. The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests. More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches. To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.
期刊最新文献
Long-term radiological progression after resection of dysembryoplastic neuroepithelial tumors: patterns and prognostic factors. Multiple presentations: a single pathology, primary central nervous system lymphoma (PCNSL). A multicenter study. Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastases. Significance of shunt placement for secondary communicating hydrocephalus in patients with high-grade glioma. Intraventricular meningiomas show size-dependent increases in peak ASL-MRI perfusion reflecting vascular heterogeneity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1